SFX by Ex Libris Inc.

Title:	Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance
Source:	Nature [0028-0836] Luan, B yr:2009

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	John J Nolan, J.J. J. "What is type 2 diabetes?" Medicine 30.1: 6-56.
description	2.	Assmann, S. "Two Novel GPCR-Type G Proteins Are Abscisic Acid Receptors in Arabidopsis." Cell 136.1 (2009): 136-148.
description	3.	Herzberg Schäfer, S. "Impairment of GLP1-induced insulin secretion: Role of genetic background, insulin resistance and hyperglycaemia." Diabetes, obesity and metabolism 14.SUPPL.3 (2012): 85-90.
description	4.	Defea, K. "beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction." British journal of pharmacology 153.Suppl. 1 (2007): 298-309.
description	5.	Nolan, Galina J. "What is type 2 diabetes?" Medicine 34.2 (2006): 52-56.
description	6.	MacKinnon, M. "Type 2 diabetes." Nursing standard 14.10 (1999): 39-45.
description	7.	"Type 2 diabetes." Diabetic medicine 29.1 (2012): 15-17.
description	8.	"Type 2 diabetes." The Lancet oncology 389.10085: 2239-2251.
description	9.	Goldfine, A. "The Great Debate: Medicine or Surgery What is best for the patient with type 2 diabetes?" Diabetes care 34.3 (2011): 763-770.
description	10.	Anonymous, S. "Type 2 diabetes." Annals of internal medicine 146.1 (2006): 322-15.
description	11.	Kitanaka, S. "Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1beta and HNF-1alpha and the abnormality of HNF-1beta mutants." The Journal of endocrinology 192.1 (2007): 141-7.
description	12.	Bagger, Jonatan I. "Impaired regulation of the incretin effect in patients with type 2 diabetes." The Journal of clinical endocrinology and metabolism 96.3 (2011): 737-745.
description	13.	Tian, L. "Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor." Endocrinology 151.7 (2010): 3049-3060.
description	14.	Nauck, M A A. "Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus." The journal of clinical investigation 91.1 (1993): 301-7.
description	15.	Shufelt, Chrisandra L L. "Contraceptive hormone use and cardiovascular disease." Journal of the American College of Cardiology 53.3 (2009): 221-231.
description	16.	Fan, Liu-Min M. "Guard cells: a dynamic signaling model." Current opinion in plant biology 7.5 (2004): 537-546.
description	17.	Donati, Robert J J. "G protein signaling and the molecular basis of antidepressant action." Life Sciences 73.1 (2003): 1-17.
description	18.	Egan, Máire E E. "Mechanisms of action of glucagon-like peptide 1 in the pancreas." Pharmacology & therapeutics 113.3 (2007): 546-93.
description	19.	Sun, Y. "When a G protein-coupled receptor does not couple to a G protein." Molecular biosystems 3.12 (2008): 849-54.
description	20.	Shirokova, E.. "The human vomeronasal type-1 receptor family - Detection of volatiles and cAMP signaling in HeLa/Olf cells." The FASEB journal 22.5 (2008): 1416-1425.